Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ahmed S. Alnaim"'
Autor:
Anroop B. Nair, Pooja Dalal, Varsha Kadian, Sunil Kumar, Minakshi Garg, Rekha Rao, Rashed M. Almuqbil, Ahmed S. Alnaim, Bandar Aldhubiab, Fatemah Alqattan
Publikováno v:
Plants, Vol 12, Iss 5, p 1168 (2023)
Natural plants and their products continue to be the major source of phytoconstituents in food and therapeutics. Scientific studies have evidenced the benefits of sesame oil and its bioactives in various health conditions. Various bioactives present
Externí odkaz:
https://doaj.org/article/1854aba192ad49d6aa47adb6bdd90af4
Autor:
Ahmed S. Alnaim, Hiral Shah, Anroop B. Nair, Vivek Mewada, Smit Patel, Shery Jacob, Bandar Aldhubiab, Mohamed A. Morsy, Rashed M. Almuqbil, Pottathil Shinu, Jigar Shah
Publikováno v:
Gels, Vol 9, Iss 3, p 213 (2023)
Poor aqueous solubility besides extensive hepatic first effect significantly decreases the oral absorption of levosulpiride, which in turn minimizes its therapeutic effectiveness. Niosomes have been extensively investigated as a transdermal vesicular
Externí odkaz:
https://doaj.org/article/2064718266394123a749bad877302cb2
Autor:
Anroop B. Nair, Sunita Chaudhary, Shery Jacob, Dhwani Patel, Pottathil Shinu, Hiral Shah, Ankit Chaudhary, Bandar Aldhubiab, Rashed M. Almuqbil, Ahmed S. Alnaim, Fatemah Alqattan, Jigar Shah
Publikováno v:
Gels, Vol 9, Iss 2, p 130 (2023)
Dolutegravir’s therapeutic effectiveness in the management of neuroAIDS is mainly limited by its failure to cross the blood–brain barrier. However, lipid-based nanovesicles such as nanoemulsions have demonstrated their potential for the brain tar
Externí odkaz:
https://doaj.org/article/bbaf60a3cd894e19af0334aa7f32bef9
Autor:
Taraswi Mitra Ghosh, Teeratas Kansom, Suman Mazumder, Joshua Davis, Ahmed S. Alnaim, Shanese L. Jasper, Chu Zhang, Aedan Bird, Praneet Opanasopit, Amit K. Mitra, Robert D. Arnold
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 380(3)
Conventional treatment with taxanes (docetaxel-DTX or cabazitaxel-CBZ) increases the survival rates of patients with aggressive metastatic castration-resistant prostate cancer (mCRPC); however, most patients acquire resistance to taxanes. The androgr